Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Appointed CFO Quarterly results Director departure Appointed director
|
Aceragen, Inc. (IDRA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
07/21/2023 |
8-K
| Quarterly results |
07/11/2023 |
8-K
| Quarterly results |
05/30/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
05/04/2023 |
8-K
| Quarterly results |
02/06/2023 |
8-K
| Quarterly results |
02/03/2023 |
8-K
| Quarterly results |
01/18/2023 |
8-K
| Investor presentation |
01/17/2023 |
8-K
| Quarterly results |
01/13/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/11/2023 |
8-K
| Other Events Interactive Data |
11/23/2022 |
8-K
| Quarterly results |
11/17/2022 |
8-K
| Quarterly results |
11/14/2022 |
8-K
| Quarterly results |
09/30/2022 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs:
|
"AGREEMENT AND PLAN OF MERGER",
"IDERA PHARMACEUTICALS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES Z NON-VOTING CONVERTIBLE PREFERRED STOCK",
"IDERA PHARMACEUTICALS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES X PREFERRED STOCK",
"EXECUTIVE TRANSITION AND SEPARATION AGREEMENT This Executive Transition and Separation Agreement , is entered into as of the date set forth on the signature page below , by and between Vincent Milano and Idera Pharmaceuticals, Inc., a Delaware corporation . BACKGROUND WHEREAS, you currently serve as President and Chief Executive Officer of the Company; WHEREAS, you and the Company are parties to that certain Severance and Change of Control Agreement and that certain Invention, Non-Disclosure and Non-Competition Agreement ; WHEREAS, the Company intends to enter into that certain Agreement and Plan of Merger by and among the Company; Bell Merger Sub I, Inc., a Delaware corporation and wholly-owned subsidiary of Idera; Bell Merger Sub II, LLC, a Delaware limited liability company and wholly-o...",
"1216 Riggins Mill Road",
"Dan Salain 837 N Barfield Drive Marco Island, FL 34145",
"Execution Version",
"Execution Version",
"EXECUTIVE TRANSITION AND SEPARATION AGREEMENT This Executive Transition and Separation Agreement , is entered into as of the date set forth on the signature page below , by and between Daniel Soland and Idera Pharmaceuticals, Inc., a Delaware corporation . BACKGROUND WHEREAS, you currently serve as Senior Vice President, Chief Operating Officer of the Company; WHEREAS, you and the Company are parties to that certain Severance and Change of Control Agreement and that certain Invention, Non-Disclosure and Non-Competition Agreement ; WHEREAS, the Company intends to enter into that certain Agreement and Plan of Merger by and among the Company; Bell Merger Sub I, Inc., a Delaware corporation and wholly-owned subsidiary of Idera; Bell Merger Sub II, LLC, a Delaware limited liability company and ..." |
|
09/28/2022 |
8-K
| Quarterly results |
08/09/2022 |
8-K
| Quarterly results |
06/24/2022 |
8-K
| Quarterly results |
05/27/2022 |
8-K
| Quarterly results |
05/17/2022 |
8-K
| Quarterly results |
05/05/2022 |
8-K
| Quarterly results |
03/31/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
12/14/2021 |
8-K
| Quarterly results |
12/01/2021 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events ... |
11/08/2021 |
8-K
| Quarterly results |
08/09/2021 |
8-K
| Quarterly results |
06/10/2021 |
8-K
| Quarterly results |
05/18/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/29/2021 |
8-K
| Quarterly results |
03/18/2021 |
8-K
| Quarterly results |
03/01/2021 |
8-K
| Quarterly results |
01/13/2021 |
8-K
| Quarterly results |
01/11/2021 |
8-K
| Quarterly results |
01/05/2021 |
8-K
| Quarterly results |
|
|
|